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Lead is one of many heavy metal ions that can effectively compete for 
the b inding sites of calcium, block the calcium channels and disturb the ion 
exchange. As a result, lead would be expected to affect the calcium­
mediated cell funct ions .  Muscle contraction and platelet aggregation are two 
important functions in which Ca2+ plays a major role and ultimately are 
affected by lead. Experiments were carned out to invest igate the effect of 
lead on mouse flexor muscle contraction and on photochemically-induced 
platelet aggregation in p ial microci rculation. A study of an acute exposure (1, 
5 ,  10 and 25 J..lM) and a chron ic exposure to lead of 0.1 mg/kg (lOW dose) and 
1 mg/kg bodyweight (h igh dose), injected subcutaneously for 7 days were 
carried out on flexor muscles.  The acute lead exposure reduced specific  
twitch tension of the muscle in  a dose dependent fashion, accelerated muscle 
fat igue and altered the frequency-tension relationship. Muscle fibers of 
chronically treated mice when examined by an electron-microscope and as 
compared to control, showed ultrastructural changes in both intramuscular 
myelinated axons and neuromuscular junct ions. Effect of chronic lead 
treatment on phtochemically-induced platelet aggregation in pial 
microcirculation was also invest igated . Findings showed a s ignificant 
decrement in the time needed to form the first observable platelet aggregate 
only in arterioles in both the low and high lead doses. This  result suggests 
an enhanced susceptib il i ty to thrombosis in these microvessels, which would 
ult imately reduce blood supply to the t issue involved. S ince Ca2+ is an 
essential ingredient in these two biological funct ions, Interference of lead with 
Jij 
C a2+ binding sites and/or Ion ic exchange could form a poss i ble explanat ion 
for these findings. 
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Lead is  a b lu ish-gray heavy metal which exists in  two forms: inorganic 
as Pb ( I I), less often as Pb ( IV) and in an organic form up to 4 Pb-C bonds. 
The inorganic form of lead is  more common and widely spread, as compared 
to the organic form. Lead occurs natural ly in the earth crust with a 
concentration of about 1 0  parts per b i l l ion and lesser than that in  sea water. 
The low melt ing point , mal leabi l i ty, softness, and corrosion resistance 
of lead a l lowed i t  to play an important role in industry (pa int ing,  p lumbing ,  
roofing, and ship bu i ld ing), cosmetics (saturn ine mascara and artificia l  
darkening of hair), medicine (saturnine drugs) and fue l  as in leaded gaso l ine .  
I t  has been an important metal to human l ife s ince midd le ages.  The o ldest 
known decorative lead object has been dated back to 4000 B . C. Water was 
d istr ibuted by lead pipes dur ing the era of the Roman Empire ( Nriagu, 1983). 
Presently, a ir, water and soi l  are found to be po l luted with lead 
becasue of its extensive use. The source of lead in the atmosphere comes 
from the emiSSIon of chemIcal act ivit ies in wh ich lead i s  used, such as 
industr ia l ,  vehicular emission and fossel fuel combust ion.  The fate of lead 
particles in the air, as with other pol lutants, is dependent upon the particle 
size. There is  a sign ificant sedimentation rate as a result  of gravitat ional 
forces found in particles > 1 0 mm in d iameter .  In water, lead can be found as 
a result of  the deposIt ion of atmospher ic lead and a lso from effluents aris ing 
from industr ia l .  domestic and transport activ it ies as wel l  as from natural 
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sources. So i l  can be contaminated by lead through the deposit ion of a i r­
borne particles lead by gravitat ional sett l ing and fa l l ing rain drops or snow. 
The b iogeochemica l  cycle of lead wh ich include the sources and the 
pathway of lead from point of exposure in the environment to the endpoint in 
the human body has been affected by man to a great degree because of the 
wide spread of lead industries (Kendler, 1993). Thus, lead is  considered a 
more serious environmental hazard than other e lements. Due to the 
introduct ion of leaded gasol ine,  lead deposit ion was found to be 2 - 5 t imes 
higher than in the pre-technologica l  state and before the industria l  revol ut ion 
(Hutchinson and Meema, 1987). Because of the variety of human exposure 
to lead i t  is necessary to give attention to the intake of lead and the 
subsequent accumulat ion in the body. 
There are miscel laneous sources of lead intake· among which food, 
drink and air are considered to be the main.  Food and l iquids are 
contaminated by lead at the source by depos ited a ir-borne part ic les, 
contaminated soi l, or during preparation for consumpt ion.  The volume of 
inhaled lead depends on the concentrat ion of lead in  the a i r  and its da i ly 
respired volume, which i s  norma l ly between 15 to 20 m3 (Sodeman and 
Sodeman, 1967). Other sources of intake include cigarettes (wh ich contain 
from 4 to 12 mg of lead each), cosmetics, some tradit ional medicine 
remedies .  ch i ldren toys and paint .  
The uptake of lead via inhalat ion, ingestion and/or through the skin 
in i t ia l ly  ends up In the b lood stream. A part of inhaled lead is  deposited into 
the a lveolar region of the lung and the rema inder IS exhaled. Lung surfaces 
absorb the Inhaled lead as dust and the smaller the particle size the faster it 
is  absorbed. Lower respiratory tract absorbs a lmost a l l  lead that reaches 
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there and around 50% of lead inhaled from car exhaust fumes may get into 
the blood stream (Gerson, 1990). The major absorption of lead takes place in 
the gastrointestinal tract, between 5 to 1 0% of ora l ly  ingested lead is 
absorbed in adults and between 30 to 50% in chi ldren . Under fasting 
condit ions, the percentage of absorption in adult increases to around 45%. 
Lead can be absorbed through the skin when contact is a l lowed for enough 
time (Gerson, 1990). Once lead is absorbed, approximately 5% lead in 
plasma is associated with red blood ce l l s  (Gerson, 1990). The rest wil l  have 
different pathways into the human body especial ly  to soft tissues and bones, 
where lead appears to be re leased at a s low rate over an extended period of 
time (Go ldsmith ,  1969). 
Because of the adverse effects of lead on biological systems, safe 
limits of exposure have been set, the U. S. Occupational  S afety and Health 
Administration (OSHA), World Health Organization (WHO), Environmental 
Protection Agency (EPA), and Center of Disease Control (CDC), kept on 
reducing the levels of l ead for exposed adult  workers. The limit of safe daily 
lead intake recommended by WHO, is 300 I1g. Assuming that absorption of 
the lead present in the blood is 1 0%, the b lood lead level wou ld  be 30 I1gl100 
g of blood (0.3 ppm) or less is safe for children. However, this assumption is 
not correct because the absorption rate in children is higher than in adults 
(Gerson 1990) .  The adverse effect(s) of lead may appear at a b lood 
concentrat ion as low as 10 I1gl100 dl  of b lood (0. 1 ppm) as manifested in the 
hematopoietic system,  nervous system and kidneys. Recently, data 
suggested that concentrations more than 10 ug/dl are too high for both 
chi ldren and adults (Gerson, 1990). The EPA estab lished an air standard for 
lead of 1 . 5  119/m3 in order to protect the exposed chi ldren from exceeding 30 
119/d l .  This standard was shown to be unacceptab le as a resu lt of data that 
became avaJiable later (Gerson, 1990) .  Currently, lead level of 25 �g/dl or 
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more i s  defined as an e levated b lood lead and lead level of 35 �g/dl or more 
i s  considered toxic (Gerson, 1990). Cases of e levated blood lead levels  in 
chi ldren were found in Austra l ia  and in U . S.A.  Gerson ( 1 990), and among 
Saudi  chi ldren 1984-1988 (Yaish ef a/. 1 993) and some cases are reported in 
U .A. E.  (Habiburrahman, 1986), in Kuwait (Shaltout ef a/., 1989), in  Oman 
(Woolf, 1990), and many other countries as a resu l t  of increased 
environmental po l lution. In the U .A.E . , lead concentrat ion was measured in 
Deira, about 50 meters from a major traffic road and lead level  was 1 . 5 � 
g/m3 (Ward and Zacarias, 1993). 
Since lead is a commonly avai lab le substance in the environment, lead 
toxicity or poisoning can be a major risk. Fanning (1988) studied the 
relat ionships between occupational lead exposure and the causes of death 
from 1926 to 1985 among lead workers . The study confirmed that there is an 
increased risk of death from cerebrovascular diseases in those workers. In 
1978,  the permissible exposure limit ( PE L) in the a ir  was lowered by OSHA 
from 150 �g/m3 to 50 �g/m3 for exposed workers. However, M ichaels  ef a/ . 
(/99 1 )  proved that lead exposure levels even below the current PEL (50 � 
g/m3) were associated with cerebrovascu lar disease morta l i ty .  To avoid  such 
risk EPA has reconsidered lowering the lead standard to less than 50 or 
perhaps to 20 ppb (Gerson, 1990). 
The major adverse effects of lead in the body are manifested in three 
organ systems: the hematological, central nervous and rena l  (Gerson 1990. 
H utchinson and Meema. 1987). Lead interfers with the formation of 8-
aminolaevulinic acid dehydratase (8-Alad), which is an important step for the 
hemesynthesls and by the insertion of iron Into protoporphyrin.  Thus, high 
level of exposure reduced hemesynthesis and causes anaemia. Lead 
pO isoning may cause damage to centra l and peripheral nervous systems as 
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manifested by al tered electroencephalography (EEG), and reduced nerve 
conduction velocity (Hutchinson and Meema, 1987). Also, lead was found to 
increase the risk of death from cerebrovascular disease ( Fanning, 1988) and 
caused abnormalities in the renal system as manifested by inhibition in the 
proximal  tubular function in which it was characterized by mild aminoaciduria, 
g lycosuria and hyperphosphaturia (Hutchinson and Meema, 1987). In  
addition, lead pOisoning caused elevated blood pressure and gastrointestinal 
malfunctions such as colic and constipation. I t  also has deleterious effects on 
reproduction such as sterility, abortion, sti l l -births and neonatal deaths 
(Gerson, 1990). 
At the cel lu lar leve l ,  a smal l  amount of lead effectively competes for 
the binding sites of C a2+, b locks the calcium channels, and disturbs the ion 
exchange (Chai and Webb, 1988; Hajem ef a/., 1990) .  Therefore, lead 
affects the calcium-mediated cel l  function. 
Experiments have been done a lmost exclusively under in vitro acute 
conditions demonistrating the adverse effect of lead ions on neurotransmitter 
release in rats (Si lbergeld ef a/., 1974; Wang and Q uastel ,  199 1 ;  Manalis ef 
a/., 1984) and the disturbance of ion exchange in red blood cel l s  of male 
human (Hajem ef a/., 1990) 
Ion exchange and neurotransmitter release are two essential steps in 
muscle contracts. The disturbance of one or both of these steps would cause 
neuromascular Impairment. inhibit sliding of fi laments causing weakness of 
the muscle contraction and accelerating the muscle fatigue. The defected 
muscle is not usua l ly wel l  coordinated upon stimu lations which would cause 
muscu lar dysfunction such as ataxia and splayed gait. Therefore, 
experiments were designed to investigate the effect of acute and chronic lead 
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treatment on mouse flexor muscle isometric contract ion,  in vivo. 
Recent reports showed that chronic exposure to lead contributed to 
cerebrovascu lar disease (M ichaels et aI., 199 1), and cerebra l  hemorrhage 
( Nowack et al., 1993). Lead neurotoxicity may a l ter the integrity of the b lood­
bra in barrier (Bress ler and Goldste in ,  1 99 1 ) . Learning disabi l i ty i n  young rats 
was reported in association with exposure to lead (Kumar and Des iraju, 
1992). Kaj i et al. ( 1 992) reported that lead may induce a procoagulant state 
of b lood, which is a r isk factor of vascular d isease. Sharp et a/. ( 1 99 1 )  found 
an associat ion between delayed p latelet aggregat ion,  in vitro, and h igh b lood 
leve ls of lead in men. 
C ircu lating p latelets do not norma l ly  adhere to the endothe l ia l  ce l l s  of 
the vascular wal l .  or aggregate, except when activated or when damage to 
the endothel ium is attained . Del ivery of b lood to various organs and proper 
t issue perfusion are s ignificant for normal  t issue function .  Development of 
thrombin in the circu latory system would result in reduced blood del ivery, and 
consequent ly, tissue hypoxialischemia. Such is very crit ical when bra in  ce l l s  
are involved. Experimental work on the effect of lead exposure on p late let 
aggregation. in vivo, is lacking. Therefore, th is Investigation was carried out 
to exami ne the Influence of two levels of chronic lead exposures on the in 
vivo p latelet aggregation in cerebral, p ia l, microcircu lat ion of the mouse. 
7 
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CHAPTER I I  
REVIEW OF LITERATURE 
Adverse Effect of Exposure to Lead: 
Chi ldren are more sensitive to lead poisoning than adu lts due to their 
higher rates of absorption, smal l  body weight and their tendency of chewing 
objects. B lood lead levels were studied in chi ldren of lower socioeconomic 
communities in Colorado, U . S.A. by Gott l ieb and Koehler ( 1 994) . .  Ch i ldren of 
six months to six years o ld were checked. About 8% of these chi ldren had 
b lood lead level of > 1 0  !J.g/dl  and 45% had less than 4!J.g/dl ,  the detection 
limit . .  These results showed a striking decline in b lood lead levels in those 
chi ldren after the deleading of gasoline. In Kuwait, b lood lead l evels in 902 
Bedouin children aged three months to five years old were studied (Sha ltout 
et aI., 1989). This study showed e levated erythrocytes pretoporphyrin (EP) as 
an indication of elevated blood lead levels, 20% of chi ldren had blood lead 
levels of > 50!J.g/dl and in e leven of them a level above 1 59 !J.g/d l; those 
chi l dren were anemic and had iron deficiency. 
Exposure to lead is a hazard which may cause a number of 
neurological changes, often resulting in severe to sub-clinical condit ions 
( Bressler and Goldstein, 199 1; Kumar and DesiraJu .  1992) .  Lead poison ing 
and acute encephalopathy as a result of exposure to lead were found in 
U .A. E.  ( Habiburrahman et al., 1986) and in Omani ch i ldren (Woolf, 1990). 
Hypo-chromic microcyt ic anemia and encephalopathy were a lso diagnosed 
among Saudi ch ildren (Yaish et a/., 1993). The major reasons for these 
cases is the use of fo lk medicine items with a high lead content of 82.5%, b int 
a l -dahab and koh l .  It is  identified that low lead level  exposure during ear ly 
chi ldhood delays motor development and d imin ished children intel lectual 
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performance which causes defects in their inte l l igence (Mahaffey, 1992; 
Baghurst et aI., 1992). An experimental study on lead-treated rats revealed 
that exposure to lead dUrIng the postnatal development age of offspring 
caused learning disabi l i ty and a s ign ificant reduction in 
e lectroencephalograph (EEG) of the motor cortex (Kumar and Oesiraju, 1992). 
The low-leve l exposure to lead and blood pressure (hypertens ion) 
relat ionsh i p  was epidemiologica l ly studied in bus drivers (Sharp et al., 1988), 
in treated hypertensives (Sharp et al., 1989), and in general populat ion that 
were exposed to lead (Morris  et a/., 1990; Aposto l i  et al., 1990; and Apostol i  et 
al., 1992). Col lect ive results of these stud ies suggested a pos it ive 
relat ionsh ip  between low levels of lead and b lood pressure. Experimental 
studies on rats confirmed the same relat ionsh ip  (Perry et a/., 1988· Bogden et 
a/. , /99 1; Lai  et al., 199 1 ). Victery ( 1 988), overviewed many exper imenta l 
stud ies on different animal species and revea led the same posit ive 
relat ionsh ip  between lead and hypertens ion.  Hypertension in  these cases 
cou ld be due to the ab i l ity of lead to a l ter the ce l lu lar calc ium metabol ism and 
induced increased vascular react ivity (Cha i  and Webb, 1 988) .  
Chronic low-level lead toxicity was examined in rats whose mothers 
had been exposed to lead before and dur ing pregnancy and lactat ion. The 
results showed a growth retardation in male and female neonatal offsprings 
and adverse effects on kidneys, spleen and respiration. Chronic lead 
exposure induced reproductive toxicity in  female cynomolgus monkey by 
depress ing the concentration of luteinizing hormone ( LH), fo l l ic le st imulat ing 
hormone ( FSH) and estradiol (E2) without affect ing the menstrua l  regu lat ion 
(Foster, 1992) .  Lead can also impa ir the male reproductive system, by 
reducing the concentration of blood testosterone level i n  human populations 
occupat iona l ly exposed to high concentrat ions of lead ( Rodami lans et 
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al . , 1988). In experimental rats, lead causes reduction of spermatogenesis by 
decreasing the binding of FSH and LH to their receptors in male rats and 
suppresses the testosterone synthesis in the testes (Wiebe et al., 1982) .  In 
1990, Alexaki et al. showed that lead had an adverse effect on sperm motility 
in bul ls .  
Effect of lead on muscle contraction: 
Experiments dealing with the effect of 1 x 1 0-5, 2 x 1 0-5, 4 x 1 0-5, 8 x 
1 0-5, 1 0  x 1 0-5 M inorganic lead on neurotransmitter release have been done 
on rats a lmost exclusively under in vitro acute conditions for a 2-hour 
treatment at each concentration (Silbergeld et a/., 1974). These results 
suggested that lead did not interact significantly with motor endp late 
receptors to change response to the neurotransmitter acetylcholine (Ach) .  It 
has been reported that the depression of conduction velocity is one of the 
earliest symptoms of low level of lead toxicity. In addition, lead was found to 
decrease the force of contraction and to increase the latency between nerve 
stimulation and muscle contraction. When the muscle was stimu lated 
indirect ly, the maximum decrease of contraction was observed with the 1 0  x 
1 0-5 M lead treatment .  This effect of lead on contraction increased when 
time of exposure was increased (Silbergeld et al., 1974).  
Manalis et al.J ( 1984) found that Ach potentia l was reduced 
significantly by Pb+2 and that Pb+2 was a potent blocker of the endplate 
potential .  The study was done in vitro in acute treatments of 1 ,  5 and 50 /-lM 
Pb+2 on the sCiatic nerve-sartorius muscle preparation of the frog. 
The effect of lead on the transmitter release at neuromuscu lar 
junctions in mouse diaphragm in vitro was studied by Wang and Quastel 
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( 1 99 1 ). Their results revealed that Pb+2 inh ibited C a+2 mediated transmitter 
releases, presumably by blocking entry of Ca+2 into nerve terminals v ia 
voltage-sensit ive channels and also that it could promote release. S ince the 
effect of Pb+2 to b lock Ca+2 entry might grow with repititive st imu lat ion, it is 
conceivable that Pb+2 is  much more effective than Ca+2 in activat ing an 
intrace l lu lar mechanism that produces fac i l itat ion, and saturates at moderate 
intrace l lu lar Ca+2, and as a result obv iates the normal faci l itat ion produced 
by Ca+2, enter ing with each impulse. 
Hechtenberg and Beyersmann ( 1 99 1 )  studied the inh ibit ion of sarco­
plasmic ret iculum C a+2 -ATPase activity by cadmium, lead and mercury, in 
vitro. The sarcoplasmic reticu lum ( S R) vesicles were iso lated from rabbit 
white h ind leg muscles, ATP hydrolys i s  was measured in the presence of 
varying heavy metal ion concentrat ions in  order to evaluate the influence of 
the three heavy meta ls on Ca+2 -ATPase act iv ity of SR vesicles. Results 
showed that cadmi um lead and mercury were potent inh ib itors of Ca+2 -
ATPase of SR membranes. The poss ib le  target for the interact ion between 
heavy meta l ion and Ca+2 -ATPase were the Ca+2 transport sites which are 
essent ia l  for the cata lyt ic function in the catalyt ic  center and inh ib it the C a+2 
pump. 
Effect of lead on the Ultrastructure 
Fowler et al. ( 1980) examined the chronic low-level lead toxicity in  
rats. Female rats were obtained at  2 1  days of age, Pb+2 acetate was added 
to the drinking water in the fo l lowing concentration: 0, 0 .5 ,  5 ,  25, 50 or 250 
ppm. Exposure of females was cont inuous from weaning unt i l  6 - 7 weeks 
later when they were mated with untreated males .  The offsprings were used 
for the study. Ultrastructural examinat ion of proximal  tubule  ce l l  from animals 
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exposed to 50 and 250 ppm for 9 months showed intranuclear inclus ion 
bodies,  swo l len mitochondria, and numerous e lectron dense Iysosomes were 
also observed. In addit ion to Pb+2 prox imal  tubule cel l ,  Iysosomes were 
found to contain e levated iron concentrat ions confirm ing the results of iron 
stain performed on h istologica l  sect ions. Both male and female offsprings 
showed lesions in kidney and spleen. These changes in the kidney were 
detected at lower Pb+2 exposure levels in males (5 ppm), but in females they 
were seen at concentrations of 50 and 250 ppm. 
Sp i t  et aI., ( 1 9 8 1 )  studied the u l trastructural  changes in the kidneys of 
rabbits treated with lead. F ifteen males and females were injected 
subcutaneously with 0,  0.25 or 0 .5 mg of lead acetate/kg bodyweight. Half of 
the low-dose group and all of the high-dose group appeared to have a h igher 
amount of the Iysosomes in epithel ial cel l s  of the proximal  convoluted tubules 
than that i n  the control group. Lysosomes appeared to have some myel in  l ike 
figures, were fil led with flocculated mater ia l  and dark amorphous masses and 
were surrounded with s ingle tr i laminar membrane with the character ist ic 
hal low underneath .  Almost al l  of Iysosomes conta ined tubular inclusions. In 
proximal  tubu les, damaged brush tubu les and injured epithel i al cel l s  were 
seen. 
Effect of lead on Blood: 
Tomokuni and Ogata (1980) examined the comparative effects of lead 
on the activ i ty of erythrocyte pyr imid ine 5 ,  nucleot idase (Py5N) and delta­
amlnolevu l inate dehydratase (ALA-D) in vivo and in vitro. The In VIVO study 
Included twenty male mice wh ich were g iven a drinking water, contain ing lead 
of 10, 50, and 250 ppm. after 27 days of exposure, blood was withdrawn. 
Both Py5N and ALA-D enzymes play important roles in cata lyzing a few steps 
In the heme syntheSIS pathway. The concentration of lead in blood was 
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significantly increased in both the 50 and 2S0 ppm groups when compared to 
the control group. In  the two 50 and 250 ppm groups, inh ib it ion of erythrocyte 
ALA-O activ ity was found especially in the 250 ppm group. However, the 
erythrocyte Py5N act ivity was not detected in al l  the groups. The in vitro 
study included 60 hea lthy men with no h istory of occupational metal 
exposure, and blood were taken from the subjects in heparin ized tubes. 
Erythrocyte PySn and ALA-O activit ies were studied as i nfluenced by several 
metals at concentrat ions of 1 0-5 and 1 0-4 mgt! . Some meta ls l ike mercury, 
cadmium, t in, s i lver, copper and lead were inh ib i tory for both erythrocyte 
enzymes and it was indicated that the erythrocyte Py5N activ ity is most 
remarkably inh ib ited by mercury whi le  the decrease in ALA-O activity was by 
lead. Inh ib i ted ALA-O activity was reported in foundry workers exposed to 
dust contain ing lead (Antonowicz et aI., 1 99 1 ). 
Tomokuni and Ogata ( 19 8 1 )  examined the relationsh ip  between lead 
concentration in b lood and the activ it ies of Py5N erythrocyte and ALA-O in 5 
groups of male mice which were g iven drinking water ad libitum, conta in ing 
lead of 0, 1 0, 50, 2S0 and SOO ppm, respectively, for 30 days. The results 
showed a negat ive correlat ion between the concentration of lead in b lood 
and the erythrocyte PySN activity. I t  was observed also that the erythrocyte 
ALA-O activity was extremely inh i bited by lead and the degree of its inh ib i t ion 
had a close correlation with the concentrat ion of lead in  blood. These results 
suggested that the erythrocyte Py5n activity was a better indicator of 
exposure to a relat ively h igh lead concentrat ion, while the ALA-O activity was 
a senSit ive index for evaluating a relatively low level of lead exposure. 
Chal and Webb ( 1 988) studied the effect of lead on vascu lar react iv i ty 
of rats which drank water containing 100 ppm of lead. Some of their results 
Indicated that there was an enlarged intracellular calcium pool in arter ies 
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from lead treated rats that maintained the contracti le effect of methoxamine 
even in the face of calcium channel b lockage. 
Grandjean et al. ( 1989) examined the delayed b lood regeneration in 
cases of lead exposure and the effect on reserve capacity. Twenty-five lead 
exposed Danish battery production workers and 25 age-matched controls 
were examined to eva luate subclinical effects on b lood formation. The 
median duration of lead exposure at the battery p lant was seven years. 
B lood was withdrawn at two different points in time and hematological 
parameters were assessed at days 5, 1 1  and 1 5  after phlebotomy. 
Erythrocyte count, hemoglobin, hematocrit, mean cell volume, mean cel l  
content, reticu locytes, serum iron and serum fervitin were determined . The 
lead-exposed workers showed a slightly lower average haptoglobin level and 
slightly lower reticulocyte counts than those of contro l .  In  general, 
hematological parameters indicated essentia l ly  normal condition ,  and no 
difference was seen in the iron status between the two groups.  At 5 and 1 1  
days after blood donation the lead-exposed workers showed a significantly 
lower number of reticu locytes, as compared to the controls .  On day 1 5, both 
groups sti l l  showed significantly decreased hemoglobin,  hematocrit and 
erythrocyte count as compared to the day of phlebotomy. Tendency towards 
lower mean cel l vo lume was not found in lead-exposed group, although 
anemIa in lead poisoning may be of the microcytic type. Two weeks after 
phlebotomy, indication of increased blood formation should be apparent. 
However, the lower hemoglobin and erythrocyte count in the lead-exposed 
workers suggested delayed blood formation .  Thus, the reserve capacity was 
reduced in lead workers despIte of the fact that minimal hematological 
changes were apparent before phlebotomy, and this effect on reserve 
capacIty became evident only after the blood loss.  
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Hajem ef al. ( 1 990) studied the influence of environmental lead on 
membrane ion transport in th irty seven males with no environmental lead 
exposure. B lood and hair lead leve ls were determined and their mean values 
were of 1 59 .9 �g/L and 5.3 �g/g respectively. Th is study revealed that Na+ -
K+ contrasport activi ty was negatively corre lated with b lood lead levels and 
that Na+ -K+ pump was negatively correlated with ha ir lead levels .  The first 
corre lat ion suggested that blood lead might inh ib i t  the red cel l  transport 
activi t ity. 
Antonowicz ef al. ( 199 1)  examined s ixty three foundry workers 
exposed to dust containing main ly lead and copper and a control group of 
non-exposed subjects to determine the levels of trace e lements ( lead and 
copper) in the serum and erythrocytes and some parameters of erythrocyte 
heme metabol i sm. B lood samples were col lected in the morn ing at the same 
t ime from each fasted subject. Results of b lood analysis ind icated 
s ign ificant ly increased levels of lead and free erythrocyte protoporphyrin in 
the exposed group. Concentrations of iron and sod ium in serum and those of 
potassium. magnesium and calc ium in erythrocytes were s ignificant ly h igher 
in the exposed group compared with non-exposed subjects. 
Falke and Zwennis ( 1990) examined the toxicity of low dose (0 . 1 - 0 .2  
mg/kg) and h igh dose (0 .8 - 1 .2  mg/kg) of  lead acetate fema le  rabb its treated 
subcutaneously with lead for 3 months. At day 125, the hemog lobin 
concentration in the h igh dose group was significant ly lower than In contro ls 
and mean lead blood was 865 119/1 . Packed ce l l  vol umes at the same day 
showed somewhat lower than the control . Red blood cel l  counts were not 
affected in the high-dose group, but mean cell volume. mean cell hemoglobin 
and mean cell hemoglobin concentrat ions were clearly affected by lead. 
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Reticulocyte count was increased in the high-dose group and basophi l ic  
st ippl ing of the erythrocytes was observed in  most animals of the same 
group. There was cons istent d ifferences in the hematologica l  parameters 
between low-dose and control groups. 
Effect of Lead on Platelet Aggregation: 
Dowd and Gupta ( 199 1 )  studied the effect of lead on intrace l lu lar free 
calcium in human platelets. One unit of fresh p latelet r ich p lasma (PRP) was 
obtained from Hudson Val ley blood services from 21 normotensive donors 
who had been off medicat ion for at least 1 5  days. The sample was d ivided in 
two ha lves, with one half serving as the lead-free control sample and the 
second half conta in l ing either 25, 1 0, 5  or 1 �M of lead acetate. The free 
Ca+2 concentrat ion in p latelets increased, compared to that of corresponding 
control and was positively correlated with the log of Pb+2 concentrations 
used. The increase in intrace l lu lar Ca+2 was not due to the presence of 
acetate in the lead-acetate treated samples, s ince control p latelets which 
were Incubated with the highest concentration of acetate used in this study 
(50 IlM) maintained free Ca+2 values with in the range of the acetate-free 
controls .  
Sharp et al. ( 1 99 1 )  selected 2398 men from the  electoral ro l l  and 
general practit ioner records to study the blood lead and p latelet aggregation 
as an evidence for a causal association, 2 1 76 of the subjects had plate let 
aggregation tests . Concentrat ions of the blood lead were determined in 2298 
subjects.  The resul ts showed a sign ificant inverse relationsh ip of decreasing 
extent of primary ADP-induced platelet aggregat ion, in vitro, With increasing 
blood lead concentration for the populat ion of the study. 
17 
Kaji et al. ( 1 992) investigated the inhib itory effect of lead on the 
release of t issue p lasminogen activator from human vascular endothel ia l  cel l s  
in  cu lture. Ce l l s  were incubated a t  370C for 24  h in the  presence or absence 
of lead n itrate (0. 0 1 , 0 . 1 or 1 .0 11M), cadmium ch lor ide ( 1 . 0 )lM), mercury 
chlor ide ( 1 . 0  11M), n ickel ch loride ( 1 . 0  11M), zinc chl oride ( 1 . 0 )lM) or copper 
chloride ( 1 . 0  11M) combined with or without thrombin (0. 5  or 1 .0 N IH units/ml) 
or endothel in- 1 ( 1 0  or 1 00 nM). Results showed the cons iderable reduct ion 
of the spontaneous re lease of t issue plasminogen activator antigen (t-PAAg) 
from these cultured endothel ia l  ce l ls .  Although tested heavy metals 
s ignificant ly inh ib ited the t-PAAg release; however, lead was the most potent 
inh ib i tor. 
1 8  
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CHAPTER III 
Materials and Methods 
Animals: 
Experiments were performed on male mice "TO" stra in with an average 
bodyweight of 32-38 g. An imals were housed in standard mouse cages, 
exposed to a 1 2-hour l ighUdark cycle  at 250C and a l l owed food and water ad 
libitum. A total of 1 00 mice were used in these experiments. In order to study 
muscle contraction, ten mice were used in an acute l ead exposure treatment. 
N inety mice were treated chronica l ly with lead acetate for 7 days. Th irty mice 
of those wh ich were chronica l l y  treated, were used in  a muscle contraction 
study and another 30 for a plate let aggregation study. The last  30 mice were 
used for the study of hematology profi le  and determinat ion of lead level In 
serum.  
Lead Acetate Solutions: 
Four solut ions of lead acetate, appropriate for four levels of acute 
treatments were prepared . The fol lOWing weights of lead acetate were 
dissolved in a normal Krebs solut ion: 0.37932, 1 . 8966, 3 .7932 and 9.483 mg 
in 1 l i tre for 1 ,  5, 10, 25 IlM concentrations; respectively .  Two solut ions of 
lead acetate were prepared for two levels of chronic treatments. Lead 
acetate was dissolved in a 5% glucose solut ion; 3 and 30 mg in 100 ml of 5% 
glucose for the low and high levels, respect ive ly. A l l  lead acetate solutions 
prepared had a pH of 7.4. 
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Surgical Procedure and Protocol for Muscle Contractions: 
In acute study, starting with normal Krebs, 1 5  - 20 m l  of solut ion were 
appl ied on the muscle for 1 5  m inutes and recording the muscle contraction at 
1 . 0  msec DC wave pulses for 5 minutes was made. Then, the muscle was 
exposed to each solut ion by order 1, 5, 1 0, 25 11M of lead acetate disso lved 
in norma l  Krebs and low calcium Krebs. 
A total of 30 mice d iv ided into three groups were used in chronic 
study. The first group served as control and was injected with glucose 
solut ion. The other two were treated with low (0. 1 mg/kg) and h igh ( 1  mg/kg) 
doses of lead. The vehicle (g lucose) and lead acetate so lut ions were 
injected subcutaneously on a da i ly basis for 7 days. On the e ighth day, the 
muscle contract ion was recorded. 
Control and treated mice were anesthetized us ing urethane (2 mg/g., 
i. p. ) and the flexor muscle of the h ind l imb was exposed. Specia l  care was 
taken to ensure that normal blood flow to the muscle was not compromised. 
The distal tendon of the muscle was cut and then t ied to a load transducer for 
measurements of contract i le  responses. Muscles were kept moist with a 
normal Krebs solution which had the fo l lowing composit ion (mM): NaCI 135 , 
KC 1 5, Ca g luconate 2. 5, Mg S04 1 ,  Na2 H P04 1 , N a H C03 15 and 
g lucose 1 1; pH of 7.4 at room temperature (23-250C). After a temperature 
equi l ibration to 370C, flexor twitch responses to supramaximal st imu l i  
del ivered to the flexor nerve were recorded on chart recorder (Lectromed. 
U. S.A.) . Twitches were evoked using 1 .0  msec DC square wave pulses 
(Harvard st imulator, U. S.A.). The muscle was lengthened unt i l  a maximum 
twitch response was el ic i ted. Indirect isometric twitch tension was measured 
in two different solutIons, the standard Krebs solut ion (2. 5 mM Ca2+) and 
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reduced Ca2+ solut ion ( 1 . 0  mM Ca2+) as an indirect measure of a safety 
factor. A re lative measure of the safety factor of synaptic transmission was 
calcu lated as the rat io  of twitch tension in low Ca2+ Krebs compared to the 
tension obtained in standard Krebs. The rat io of th is, was taken to represent 
the proportion of fibers in the muscle where the endplate potent ia ls was 
above threshold for generating of a muscle act ion potent ia l ,  i . e. ,  a value 
d irectly proport ional  to transmitter output of all neuromuscu lar junct ion (NMJ) 
as Ca2+ concentrat ion is  reduced ( Banker et aI . ,  1983; AI S hua ib and Fahim, 
1990). 
In chronica l ly  treated animals frequency-tension re lat ionship was then 
tested using a tra in of frequencies of stimu lat ion ranging from 2 - 25 Hz 
separated by a 1-m inute of rest. 
Electron microscopy: 
At the end of the contract ion experiments, muscles were exposed and 
bathed in situ for 10 minutes with 4% g lutara ldehyde in 0 . 1 M phosphate 
buffer (pH 7 .4) .  Muscles were then removed , p laced in buffered 
g lutara ldehyde of the same concentrat ion at 40C for an addit ional 2 hour 
period. Muscles were then washed for 1 hour in 0 . 1 M phosphate buffer and 
sta ined for 3 minutes for chol inesterase activity accord ing to the method of 
Tennyson et al. ( 1977). Next, the specimens that contained cholinesterase­
posit ive endplates were d issected free then post fixed for 1 hour in 2% 
osmium tetroxide in phosphate buffer (pH 7.4), then dehydrated and 
embedded in Spur res in .  Thin sect ions (80 nm) of longitud ina l ly oriented 
muscles were cut us ing an MT 6000 ultramicrotome ( Du pont ,  USA). The 
sect ions were subsequently stained with 2% alcoholic uranyl acetate for 10 
minutes and alkal ine lead citrate for an addit ional 10 m inutes. The stained 
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sections were examined with a Phi l i ps C M-10 electron microscope ( Phi l ips, 
Hol land). Sections were taken at random from 50 b locks of embedded 
t i ssues; in each block only one thin section contain ing one or more endplates 
was taken for examinat ion. 
Hematological Parameters and Lead Level in Serum: 
Fifteen mice, 5 from contro l, chronic low and high treatment groups 
were used for determination of hematolog ica l  parameters. For this  purpose, 
the carotid artery of l ight ly anesthetized mice (urethane 1 mg/g, i . p.) was 
exposed, severed and blood was co l lected in  EDT A vacutainers. 
Hematologica l  parameters; red b lood cel l  (RBC) count, white blood ce l l  
(WBC) count, p latelet count, hemog lobin (Hb), mean ce l l  volume (MCV), 
mean cel l  hemog lobin ( MCH) and mean ce l l  hemog lob in concentrat ion 
(MCHC) were determined by an automated hematology ana lyzer (Coulter 
STKS, . U . S .A.). An addit ional number of 1 5  mice 5 from each group, was 
used for determination of lead level in serum.  B lood was col lected, as above,  
but in capped plastic v ia ls  contain ing no anticoagulant .  B lood was a l lowed to 
clot ,  then the conta iners were spun in a centr ifuge at 11, 800 rpm for 5 
minutes and the resultant serum was co l lected. Determinat ion of lead was 
carried out on serum by a Perk in-Elmer induct ively-coupled p lasma 
spectrophotometer (model I C P-Plasma 400, U . S . A.), comp lete with an 
autosampler. Lead content in  serum samples was read against appropriate 
b lank and standard solut ions. 
Experimental Protocol for the Platelet Aggregation Study: 
Three groups, 10 m ice each, were used in this  study. One group 
served as control and the others were treated chronica l ly, for 7 days, with 
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lead. Two leve ls of lead were administered, a low dose of 0. 1 mg/kg and a 
h igh dose of 1 . 0 mg/kg. Isovolemic inject ions (0. 1 ml/30g bodyweight) of the 
lead acetate solut ions and that of vehicle were made subcutaneously on a 
dai ly  basis .  Except for their intended treatment, mice of a l l  groups were 
handled in the same manner. On the eighth day, the day after chronic 
treatment, p latelet aggregation by photochemica l  means in cerebra l ( p ia l) 
microvasculature was carried out. 
Cranial Window and Microscope-TV Closed Circuitry: 
M ice were anesthet ized with urethane ( 1  - 2 mg/g body weight ,  i . p.) 
and the trachea was incubated. A cran iotomy (3 x 3 mm) was performed on 
the left s ide ( Figure 1 ), using a micro-dr i l l  and the dura was str ipped open 
( Rosenblum and EI-Sabban, 1977) .  Only untraumatized preparat ions were 
used ( Figure 2) and those showing trauma to e ither m icrovessels or 
underly ing brain t issue were d iscarded. The mouse was then placed on the 
stage of a microscope ( BH2 fluorescence, O lympus, Japan) to wh ich a v ideo 
camera and a recorder were attached (Tanira ef aI., 1994). A heating mat 
was p laced under the mouse and body temperature was ra ised to 370C 
(with in 30 min), as monitored by a recta l thermoprobe ( Physitemp, model 
RET-3,  U . S .A.) connected to a temperature reader ( Physitemp, Thermalert 
model TH-5, U . S .A.). The crania l  preparation was moistened cont inuously 
with art ific ial cerebrospinal flu id  (AC S F) of the following composit ion (mM): 
NaC I  1 24, KCI 5. NaH2P04 3, CaCI  2 .5, MgS04 2 .4, NaHC03 23 and 
glucose 1 0; pH of sub-f ield 7.3 - 7.4. A field conta in ing arter io les and 
venules of 25-50 microns in d iameter was chosen. Such a sub-field was 
v ideo-taped prior to and during the photochemical insult .  A l l  microscopIc 
observations were made using a 4x objective lens and a 1 0x eye piece. 
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A schcmatic presentation of the cranial preparation and the pial microvascular arrangement. 
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Figure 2 : An intact sub-microvascular field, before the photochemical insult. It contains a venule, in a 
horizontal orientation, and an areteriole, the warped vessel to the right third of the photograph. 
The photograph was taken before the sodium fluorescein dye was injected. 
IV 
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Photochemical Induction of Platelet Aggregation, in vivo: 
The photochemical Insult was carned out by injecting sodium 
fluorescein (0 . 1 mil 25 g bodyweight of a 5% solution) via the tail vein, which 
was a l lowed to circulate for 30-40 sec. The cranial preparation was then 
exposed to a stabilized and Intense (44000 lux candle/cm2) mercury light. 
The combination of l ight and dye produces a free radical which injures the 
endothelium of the microvascular lumen ( EI-Sabban ef aI., 1994). This, in 
turn, causes platelets to adhere at the site(s) of endothelial damage and then 
aggregate (Figure 3). P latelet aggregates grow in size until complete 
vascular occlusion (F igure 4). The time when the first observable aggregate 
appeared (time to first aggregate) and until full vascular occlusion (time to 
flow stop) in both artenole and venule were al l measured in seconds with 4 
stop watches. The time of aggregate growth was calculated, as the 
difference between the time to flow stop and the time to first aggregate. 
Diameters before Insult and after full vascular occlusion were measured from 
video recordings and changes were calculated . 
Statistical Analysis: 
One-way analysIs of variance was used to test statistical differences 
among the 3 groups of the acute and chronic lead treatment studies and the 
Student 't' test was employed In the acute lead treatments of the muscle 
contraction study. 
Figure 3: The same microvascular sub-field with platekt aggregates in hoth the arteriole and venule. 
Ikcallse platele ts  aggregate faster i l l  venules, the relat i ve s i le of aggregat es is larga in t he venule 
thall  in t he arter iole. 
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Figure 4: The same microvascular sub-field with massive platelet aggregates in both the arteriole and 





RES U LTS AN D DATA PRESENTATIONS 
Effect of lead on muscle contraction: 
The isometric force of contract ion in  response to supramaximal nerve 
stimulat ion was between 0.4 to 1 . 1  g ;  that was a function of the muscle s ize. 
In acute treatment of lead that d issolved in  normal calcium Krebs, 1 /2 
decay t ime was not s ignificant ly different in  the different concentration of lead 
compared to the contro l .  However, the rise t ime and twitch tension were 
s ignificantly decreased in a dose-related manner with the h ighest effect at 25 
�M. The lowest effect in rise t ime at 1 �M and in twitch tension at 5 �M, 
(Table 1 ) . Low calcium Krebs depressed muscle twitch tension in control and 
acute lead-exposed mice at the same proportion (Table 1 ) . 
C hronic lead treatment revealed no significant difference in the rise 
t ime and 1 /2 decay t ime as compared with the control, but s ign ificantly 
decreased twitch tension in both low and high dose with a Sign ificant 
increase of safety margin in both doses as compared with contro l  (Tab le  2) .  
F igure 5 shows the percentage of  twitch tension at  the zero t ime of  recording 
and after 30 minutes. The result showed a significant decrease in low and 
high doses as compared with control, in both t imes. At the zero time contro l  
twitch tension considered to  be 1 00%, low dose was 90. 1 % and h igh dose 
about 89 . 1  %. In control animals twitch tension was reduced to 92. 1 %, in  low 
dose of lead to 72.3% and in h igh dose of lead to 70.3% after th irty minutes 
of recording.  The absolute values showing in table 3. The difference of the 
twitch tension that occurred after the th i rty minutes was higher in  low and 
high dose of chronic lead treatments than in contro l .  In  brief, chronic lead 
3 1  
Table 1 .  Effect of acute Pb2+ exposure on flexor muscle contract i le properties. 
Treatments Control 1 �M Pb2+ 5 �M Pb2+ 1 0  �M Pb2+ 
Rise t ime (ms):  
Normal Krebs 0.09 ± 0.007 O.OS ± O .OOS* 0 .06 ± O .OOS* 0.06 ± 0 . 009* 
Low Ca2+ Krebs O.OS ± 0 .024 * 0 .06 ± 0.026 0 .06 ± 0 . 034 0.07 ± 0 .032 
1 /2 Decay time (ms) :  
Normal Krebs 0.24 ± 0.01 2 0.20 ± 0 .04 1  0.20 ± 0.049 0.22 ± 0 .020 
Low Ca2+ Krebs 0.20 ± 0. 046 0. 1 S  ± 0. 1 04 0.20 ± 0 .069 0 .20 ± 0 .035 
Twitch tension (g) :  
Normal Krebs 0 .40 ± 0 .053 0 .34 ± 0. 054 0.2S ± 0 .049* 0.25 ± 0 .04S* 
Low Ca2+ Krebs 0 .32 ± 0. 1 49 0.27 ± 0. 340 0 .26 ± 0 . 1 69 0.24 ± 0. 1 55 
Values are Mean ± S E  ( No. Animals= 1 0) 
* S ignificantly different from the Control Group ( P  < 0.05) .  
25 �M Pb2+ 
0.06 ± 0. 0 1 9* 
0 .06 ± 0.203* 
0 . 1 9 ± 0.04S 
0. 1 9  ± 0.239* 
0.24 ± 0.262* 
0.20 ± 0.034* 
w 
N 
Table 2.  Effect of chronic lead treatment on flexor muscle contract i le properties. 
Treatment 
R ise time (ms) 
1 /2 Decay t ime (ms) 




0. 039 ± 0 .003 
0.260 ± 0 . 01 2 
1 . 0 1 0  ± 0.060 
1 . 078 
Values are mean ± SE ( No. Animals= 1 0) 
• S ignificant ly different from the control group ( P < 0.05) 
Low dose 
(0. 1 mg/kg) 
0 .037 ± 0 .002 
0 . 230 ± 0 .01 6 
0 .91 0 ± 0 .060· 
1 . 277 
H igh dose 
( 1  mg/kg) 
0.038 ± 0 . 003 
0.240 ± 0 .01 4 




























IIIZero time of recordings 
iZJAfter 30 minutes of recordings 
Figure 5: Chronic lead treatment decreases twitch tension. 
w 
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Table 3 .  Chronic lead treatment decreases twitch tension. 
Treatment 
At zero t ime 
After 30 min of recording 
Control 
(5% g lucose) 
1 . 01  ± 0 .06 
0 .93 ± 0.07 
Values are mean ± SE ( No. Animals= 1 0) 
* S ignificantly d ifferent from the control group ( P < 0.05) 
Low dose 
(0 . 1 mg/kg) 
0.91 ± 0 .06 
• 




0.90 ± 0.058* 
0 .71  ± 0 .040* 
w 
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treatments not only decreased the twitch tension but also decreased it in  a 
t ime dependent fashion .  
F igure 6 showing the percentage of in it ia l  contraction after 200 stimul i .  
The control was reduced from 100% at the beginn ing of the st imulation to 
75.7% after 200 stimul i  and sign ificantly reduced to 32.7% in low dose group 
and to 36 .0% in h igh dose, Thus both low and h igh dose accelerate the 
muscle fatique after a train of 200 st imul i .  The absolute values showing in 
table 4.  Figure 7 and table 5 showing the specific tension (Tension/Flexor 
muscle we ight) as response to frequency of 2, 5, 10, 15 ,  20,  25 Hz. The 
frequency-tension relat ionship of low dose group was not significantly 
d ifferent from that In control but s ignifi cantly h igher in h igh-dose group as 
compared to control. 
Electron Microscopy : 
The character ist ic ultrastructural features of endplates in mature 
mouse flexor muscle were generally s imilar to that descr ibed by Santa and 
Engel ( 1973). Nerve terminals were observed to l ie with in an ova-shaped 
depression of the muscle fiber surface (pr imary synapt ic cleft) and usually 
covered by a Schwann cell. In th is reg ion, the muscle' s sarcolemma 
extended inward and formed an elaborate system of both pr imary junct ional 
folds and secondary clefts.  The presynaptic nerve terminals contained 
numerous numbers of synapt ic vesicles. m itochondr ia ,  glycogen granules, 
neuro-filaments and a few mlcrotubules. 
The most str ik ing observat ion between unoperated (control) and 
chronically lead treated animals was the s ign ificant differences in the 
frequency With wh ich a particular ultrastructural feature occurred. After 7 
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Control Low dose High d ose 
F i gure 6 :  C h ronic lead treatment accelerates m u scle fat igue after a tra in  of 200 st imul i .  
t.J 
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Table 4 . Chronic lead treatment accelerates the muscle fatigue after a tra in  of 200 stimul i .  
Treatment 
Beginn ing of tra in of 1 0 Hz (g) 
End of train of 1 0 Hz (g) 
Control 
(5% g lucose) 
3. 00 ± 0 .09 
2 . 25 ± 0 .30 
Values are mean ± S E  ( No. Animals= 1 0) 
* Sign if icant ly d ifferent from the control group ( P < 0.05)  
Low dose 
(0 . 1 mg/kg) 
3. 1 5  ± 0. 3  
0 .98 ± 0 .3  
* 
H igh dose 
( 1  mg/kg) 
3. 43 ± 0.3 
1 08 ± 0. 3* 
l.) 
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F i g u re 7 .  Chronic lead treatment  a lters frequency-tension relationship .  
* Conlrol 
• Low dose 
¢ High dose 





Specif ic tension (g) of 
2 HZ 
5 HZ 
1 0  HZ 
1 5  HZ 
20 HZ 
25 HZ 
Table 5 .  Chronic lead treatment a lters frequency-tension relationship.  
Control 
(5% g lucose) 
23 .7  ± 0 . 9  
29 .8  ± 2 . 0  
45 .2  ± 4 . 5  
5 8 . 2  ± 1 3. 3  
62 .7  ± 1 5 . 1  
67 .7  ± 1 5 . 5  
Low dose 
(0 . 1 mg/kg) 
2 2 . 5  ± 0 .6 
32 .8 ± 1 . 5 
52 . 8 ± 4 . 9  
6 1 . 4  ± 2 . 4  
65.0 ± 3 .2  
70 .6 ± 3 .9  
Values are mean ± S E  ( No.  Animals = 1  0)  
• S ignificant ly d i fferent from the control group ( P < 0. 05) 
H igh dose 
( 1  mg/kg) 
28. 3 ± 2 . 8  
49 .6 ± 4 .9  
• 
• 
69 . 4  ± 7 . 1
* 
82 .6 ± 5.6 
* 
8 1 . 8  ± 5 . 3  
* 




days of chron ic lead treatments, endplates from treated and control muscles 
were found to exhibit a large number of ultrastructural alterat ions. Evidence 
of degeneration as well as regenerat ion occurred side by side along With 
normal synaptic s ites with in endplates of treated and control muscles. Figure 
8 is showing the normal ultrastructural feature of the peripheral intramuscular 
myel inated axon of the control animals, wh ile figure 9 is showing the 
ultrastructural changes of the peripheral intramuscular myelinated axon of the 
chronically treated animals with high dose of lead. The changes include, 
swollen and damaged mitochondria ,  reduced axonal cytoplasm, increased 
disorganisat ion of the microtubles and neurofilaments, and more abundant 
sarcoplasmic ret iculum (SER). Figure 1 0  is showing the normal 
ultrastructural feature of neuromuscular junct ion ( MNJ) of control animals and 
figure 1 1  i s  showing the ultrastructural damage to NMJ in high dose of lead 
treated animals, the damage conta ined atrophic of nerve terminals, Schwann 
cell remnant interposed between nerve and muscle, d isrupt ion of 
mitochondria, reduced number of synapt ic  veSicles and increased SER or 
other membranes organelles. 
Figure 1 2  is showing the ultrastructural feature of normal flexor muscle 
in control animals, and figure 1 3  is showing an extens ive disruption of 
sarcoplasmic mitochondria with myel in l ike debr is seen inside the swo llen 
mitochondria in high dose treated animals.  
Hematological paramete rs and l ead l evel in serum: 
Data of hematological parameters and of lead level in serum from the 
control and chron ically treated mice are shown In Table 6. There were no 
Significant differences In the determ ined blood parameters among the mice of 
the 3 groups used. with the exception of hemoglobin between the control and 
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Figure 1 0 : A neuromuscular j unct ion i n  a control  mouse .  A nerve term i nal  fu l l  of synaptic vesicles i s  seen 
overlying the postsynaptic region of the m uscl e .  The muscle ' s  sarcolemma i n  t h i s  region con tai ns 
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Figure 1 3 : A flexor m u scle taken from chronical l y  l ead-treated mouse depicting extensive d isruption of 
sarcoplasmic m i tochondria.  Note that myel i n - l i ke debris are seen i nside the swol len mitochond ria .  
� 
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high-dose lead group (P<0.02) .  Lead leve ls in  serum of the low and high­
lead groups were sign ificantly higher than that of control (P<  0 .03 and 
P<0.003, respectively) .  Between the two lead treatments, the high dose 
group had a significant ly higher (P<0. 0 1 ) lead level in  serum. 
Effect of lead on platelet aggregation: 
Effects of chronic lead treatments on the t ime required for p latelet 
aggregation and for fu l l  vessel occlusion in  p ia l  m lcrovessels are summarized 
in Table  4. In arter io les, times to first aggregate for the high and low-lead 
groups were s ignificantly shorter than that of control ( P <0 .001  and P <0.02 ,  
respect ive ly). Time to  first aggregate in arterio les of  the high-lead group was 
s ign ificantly shorter ( P <0.05) than that of the low-lead. Times unt i l  flow stop 
and of aggregate growth In arterio les were not s ign ificant ly different among 
the 3 groups studied. In venules, no s ign ificant differences were observed in 
the t ime needed for first aggregate to appear among the control ,  lOW-lead and 
high-lead groups. In both arter io les and venules,  vascular d iameter changes 
throughout the photochemical insult among the 3 groups were within a very 
narrow range and no statist ica l ly s ignificant differences were present (Table 
7) .  
48 
Table 6. H ematological responses to chronic lead treatment and lead level in serum.  
Group 
Hematological parameter: 
White blood cell count,  x 103/mm3 
Red blood cell count ,  x 1 06/mm3 
Platelet count,  x 1 03/ m m3 
H e moglobin ,  g/dl 
Mean cell volume,  fl 
Mean cel l  hemoglobi n ,  pg 
Mean cel l  hemoglobin 
concentrat ion,  g/dl 
pb+2 in seru m ,  ppm 
Control 
(5% g lucose) 
6 . 4 7  ± 3 . 00 
9 . 1 2  ± 0 . 58 
797 . 30 ± 1 09 . 40 
1 5 . 53 ± 0 . 3 5  g 
4 8 . 7 7  ± 0 . 7 1  
1 6 .65 ± 0 . 5 5  
34 . 4 0  ± 1 . 00 
0. 1 9 ± 0 . 1 6 �' � 
� ,� means on the same l ine are s ignifica ntly different (P<0.005) .  
f't means on the same l ine are significantly different (P<0. 0 1 ) .  
� , - means o n  the same l ine are significantly different  ( P<0.03) .  
Low dose 
(0. 1 mg/kg) 
6. 37 ± 2 . 1 6 
8 .99 ± 0 . 36 
8 1 7 .00 ± 7 8 . 2 0  
1 5 . 4 5  ± 0 . 76 
4 9 . 4 3  ± 0 . 4 2  
1 6 .65 ± 0 . 2 1 
33.83 ± 1 .00 
0 . 2 5  ± 0 .04 f.f 
High dose 
( 1 . 0 mg/kg) 
7 . 2 3  ± 1 .6 5  
8 . 9 3  ± 0 .60 
864 .80 ± 98.20 
1 4 . 70 ± 0 .60 f 
4 7 . 98 ± 0 . 74 
1 6. 58 ± 0 . 4 0  
33.70 ± 1 . 00 
0.67 ± 0 . 2 1  Q,Q 
� 
\0 
Table 7 .  Effect of chronic lead treatment on p latelet aggregation in pial  microcirculation of the mouse.  
Group 
No. of mice 
Mouse weight (g) 
Arterioles:  
I nitial diameter (micron) 
F inal diameter (micron) 
% diameter change 
Time to 1 st aggregate (sec) 
Time to flow stop (sec) 
Aggregate growth (sec) 
Venules:  
In itial diameter(micron) 
Final  diameter (micron )  
% diameter change 
Time to 1 st aggregate( sec) 
Time to flow stop (sec) 
Aggregate growth (sec) 
Control 
(5% glucose) 
1 0  
33 ± 4 
4 5  ± 9 (n=9) 
44 ± 1 0  (n=9) 
-4 ± 9 (n=9) 
1 55 ± 25 �.f 
284 ± 9 1  
1 29 ± 87 
55 ± 1 3  
53 ± 1 3  
-6 ± 1 1  
30 ± 9 
1 76 ± 74 
1 46 ± 73 
�.� means on the same l ine are significantly d ifferent (P<0.00 1 ) .  f'f means o n  the same l ine are s ignificantly d ifferent (P<0.02) .  
�.- means on the same l ine are significantly d ifferent (P<0 .05) . 
Low dose H igh dose 
(0. 1 mg/kg) ( 1 .0 mg/kg) 
1 0  1 0  
3 5  ± 4 35 ± 5 
50 ± 6 48 ± 1 0  
4 7  ± 6 47 ± 1 2  
-6 ± 9 -3 ± 1 0  
1 1 3 ± 44 Q.� 71 ± 1 8  
303 ± 65 2 59 ± 92 
1 90 ± 34 1 87 ± 85 
56 ± 1 0  5 1  ± 1 0  
5 3  ± 8 49 ± 1 2  
- 5  ± 4 -4 ± 5 
2 5  ± 1 1  2 5  ± 9 
1 72 ± 85 1 75 ± 68 








Results of the muscle contract ion experiments with acute and chron ic 
treatments showed a reduct ion in twitch tension of  the muscle.  The chron ic 
lead treatment acce lerated the muscle fat igue faster than in  the control group 
and a l tered the frequency-tension relat ionsh ip. Muscle contract ion has been 
clearly affected by lead in  two poss ib le  ways, ind irect ly on pre-synapt ic 
neuron,  or directly on muscle itself ( post-synaptic) .  In the presynapt ic  
neuron, i t  is  important to know that  in  order to have a contract ion the 
message or the impu lse from motor neurons must reach the muscle and 
st imu late i t .  In  order to pass the impulse to the muscle, the impulse must 
reach the synaptic end bulb of the presynapt ic neuron and depolarize it by 
act ivat ing the sodium-potassium (Na+ -K-) pump. Alterat ion of the membrane 
potentia l  of the nerve causes the voltage-gated ca lcium channels in  the bu lb 
to open.  Calcium ions flood in from intersti t ia l  flu id and attract synaptic 
vesicles to the p lasma membrane and help l iberate the neurotransmitter 
(acety lchol ine)  molecules from the vesicles into the synaptic cleft. Therefore, 
any d isturbance wh ich wou ld occur in  any of these processes would affect 
the muscle contract ion. Lead has the abi l i ty of b locking the calcium channels 
and affecting the depolarizat ion of the nerve by a l tering the sodium­
potass ium pump (Hajem 1990) .  I n  addit ion to the above, Pb2+ acts as a 
competit ive antagonist for Ca2+ (Manal is  et al. , 1 984) .  Thus it is  
reasonable for lead to have an adverse effect on muscle contract ion 
Ind irect ly.  
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The postsynaptic (muscle) part p lays a major ro le in  muscle 
contract ion.  When the neurotransmitter, acety lcho l ine,  reaches the muscle 
fibers at the s i te of neuromuscular junct ion i t  combines with the receptors on 
the sarcolemma of the muscle and a lters permeabi l i ty to Na+ and K-, to 
wh ich in response a muscle act ion potent ia l  is generated. As the act ion 
potent ial  reaches the sarcoplasmic ret icu lum an interact ion between present 
Ca2+ and the sarcoplasmic ret iculum enzyme C a2+ -ATPase occurs to 
transport ATP,  wh ich provides the energy for muscle contract ion.  This  a l lows 
for the s l id ing of act in  over myosin  fi laments and the muscle to contract .  I f  
lead causes the blockage of Ca2+ channels and the changing or a l ter ing of 
the Na+ and K- pump, it would be expected to affect muscle contract ion in an 
ind irect way. In addit ion,  lead may act as an inh ib itor of Ca2+ -ATPase of the 
sarcoplasmic reticu lum membrane ( Hechtenberg and Beyersmann, 199 1 ) .  
The act ion of  lead on blocking the C a2+ channels ,  changing the Na+ 
and K- pump and inh ib it ing Ca2+ ATPase would  resul t  in  a reduction of  the 
muscle twitch tens ion .  However, th is effect of  lead does not  exp la in  the 
a l tered frequency-tension relat ionsh i p  observed. I ntrace l lu lar ca lc ium 
concentration can increase even if there i s  a b lockage of calc ium channels 
due to the regulat ion mechanism of calc ium through the cel l  membrane. 
Affected mechanisms may include: such as Na+/K- cotransport system, Na+­
K- pump, Ca+ K+ pump, voltage-gated calcium channels and osmotic 
pressure. In addit ion, there is  also the present of calc ium pools in the cel l  
and the calcium binding sites of m itochonderia,  endoplasmic ret iculum and 
ca lc ium b inding proteins may be affected. Chai  and Webb ( 1988) examined 
the re lat ionship of lead and intrace l lu lar ca lc ium concentrat ion in  the arteries 
and found that there was a high intrace l lu lar  calc ium concentration in  calcium 
pools even in  the  presence of calc ium channels b lockage.  Dowd and Gupta 
(/99 1 )  revealed that in  the presence of lead, there is  an increase of 
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i ntrace l lu lar calcium in  human p latelets, wh i le  Wang and Quastel ( 1 991 ) 
reported an increase in the intracel lu lar  Ca2+ in  the motor nerve termina l  in 
the presence of Pb2+. Accordi ngly, if we assume that there was a h igh 
concentration of intracel lu lar calc ium in  muscle fibers as wel l  as motor nerve 
terminal  in the presence of lead, insp ite of the fact of calc ium channels 
b lockage, that wou ld  g ive a su itable explanation for the a l tered frequency­
tension relationship.  
As the muscle stimulated, the C a2+ is  used to supply the act in and 
myosin with enough energy (ATP) to a l low the sl id ing of the fi laments and the 
muscle to contract. With an increased i ntrace l lu lar Ca2+, an increased 
energy would be suppl ied and a strong force of contract ion occur. Many 
experiments were carried out in vitro which support our find ings ( S i lbergeld ,  
ef  a/. , 1 974, Manal is ,  ef a/. , 1 984, Wang and Quasta l ,  1 99 1  and Hechtenberg 
and Beyersmann, 1 991 ) ;  however, there were no in vivo experiments to 
compare our findings with. 
F ina l ly ,  whether lead affects the presynaptic and/or the postsynapt ic 
the resu lts would be induction of neuromuscular impairment, which in  turn 
causes muscle weakness and atax ia in an imals and possib ly  to humans who 
are chron ica l ly  exposed to lead.  
Electron Microscopy 
The electron microscopy examinat ion showed u ltrastructural changes 
in the axon terminals of the motor neuron as a resul t  of due chron ic exposure 
to lead. The ul trastructural features of peripheral myel inated axon of the h igh 
dose-treated an imals showed neurophathy. Such consisted of the presence 
of vacuoles and the damaged mitochondria,  the feature of the u l trastructure 
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of neuromuscular junct ion also showed the damaged mitochondria in  the h igh 
dose group. Previous stud ies revealed ultrastructura l changes in the 
myocardium due to lead exposure, ( La l  ef a/. , 1 991 ) .  U l trastructural damage 
to the kidneys were observed in rabbits wh ich were treated with lead. The 
damage consisted of increased amount of Iysosomes in  epithe l ia l  cel l s  and 
loss of brush border in  the stra ight part. U ltrastructural studies to rat k idneys 
revealed,  mi tochondrial swel l ing and i ncreased number of Iysosomes with in  
prox imal  tubule cel l s  ( Fowler ef  aI. , 1 980; S pit  ef a/. , 1 98 1 ) . 
If lead has the abi l i ty to increase Ca2+ influx into the nerve termina l ,  
th is  would result in an increase in the levels of intrace l lu lar free calc ium. I t is  
known that m itochondria can bind ca lc ium revers ib ly and it has been shown 
that, in a large number of t issues, m itochondria are able to take up ca lc ium 
against large concentration gradients. Subsequently, m itochondria should 
sequester this excess ca lcium in  the nerve term ina l  to ma inta in a steady level 
of intracel lu lar  ca lc ium. Consequently, as the ca lc ium level increases 
dramatica l ly, the mitochondria might be unable to cope with the excess and 
wh i l st "overworking" in  an attempt to ma inta in control over intrace l lu lar Ca2+ 
levels they may be physica l ly  damaged. This cou ld  be manifested by the 
swo l len appearance, with the d isrupted interna l  cyto-arch itecture observed in 
the present study. 
Hematological parameters and lead level in serum: 
Hematological data revealed that the chroniC treatments of lead used 
in  th is study did not sign ificantly a l ter the blood picture of m ice except that 
concerns hemoglobin. Hemoglobin was found to be s ign ificant ly lower than 
that of control (P<0.02) ,  wh ich confirms previously reported work by Falke 
and Zwennls ( 1 990) .  These workers, however. reported a sign ificant 
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reduct ion i n  MCV, MCH and MCHC in  female rabbits subjected to a chronic 
treatment ( 1  mg/kg, s .c. )  with lead acetate. The durat ion of their chronic 
treatment was much longer than that of th is study, up to 7 .5  months, which 
may be required to show an effect on these parameters. In  our study only 
f ive animals in  each group were hematolog ica l ly  examined. Also, Fa lke and 
Zwennis ( 1 990) used female rabbits i n  their  study whi l e  we used male m ice. 
Data of the level of lead in serum ind icated that such treatments were 
effective in ra is ing lead concentration ,  i n  a manner correspond ing to the 
admin istered dose. 
Platelet Aggregation: 
A photochemica l  method, or known as a l ight/dye method, was used in 
th is  in vivo experiment to study p latelet aggregation in  a l l  animals .  A certa in  
vo lume of dye such as sodium fluorescein ,  rose bengal or methylene b lue is  
i njected via the ta i l  ve in .  The dye i s  a l l owed to ci rcu late for nearly 30 
seconds. The fie ld of  the study wou ld  then be exposed to usua l ly intense 
l ight either mercury or a He Ne laser beam. The l ight act ivates the ci rcu lat ing 
dye to l iberate a free radical wh ich injures the endothel ium of the vessel .  
P late let start to adhere to the endothel ium in  response to the injury and then 
to aggregate. 
These data of p latelet aggregation revealed s ign ificant ly shorter t imes 
for the appearance of the first aggregate in  p ia l  arterio les of the lead-treated 
groups.  Such resu lts were in a dose-dependent manner and corresponding 
to the lead level in  serum; thus ind icat ing an increased suscept ib i l ity to 
thrombosis in lead exposed animals.  Such a f inding adds another d imension 
to the adverse effects of exposure to lead. 
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Our data demonstrated enhanced suscept ib i l ity to thrombosis in 
cerebral m icrovessels as a result  of chronic exposure to lead. There are no 
sim i lar in vivo studies to which we can compare our results .  In  contrast to 
the finding of Sharp ef a/. ( 1 991 ) ,  p latelet aggregat ion was enhanced rather 
than de layed. Two factors may account for such d iscrepancies between our 
study and theirs; a)  these workers col lected b lood from human subjects ,  and 
b)  p latelet aggregation was carried out in vitro. 
Although the present study was not designed for test ing any of the 
mechanisms involved; severa l postulat ions can be made wh ich may help 
expla in  the enhanced platelet aggregat ion reported here in .  F i rstly, exposure 
to lead was reported to d isrupt the blood-bra in  barrier (B ressler and 
Goldstein ,  1 991 ) .  This would imp ly damage to the microvascular 
endothe l ium or, at least, an increased possib i l i ty for easier damage. 
P latelets are known to adhere and aggregate at s ites of endothel ia l  injury 
( Rosenblum and EI-Sabban, 1 977) .  Secondly, Kaji ef a/. ( 1 992) reported that 
lead interfered with the re lease of p lasminogen activator by cultured human 
endothel ia l  ce l ls ,  thus created a pro-p latelet aggregatory condit ion.  These 
workers made reference to the possib le  i nterference of lead with calc ium for 
creating such procoagulatory condit ion.  Th i rdly,  the role  that calcium p lays in 
p latelet function cannot be ignored.  The reported increases in  the 
intrace l lu lar calcium pool in arteries of rabbits exposed to lead (Cha i  and 
Webb, 1 988) and in the intrace l lu lar free calcium in human p latelets (Oowd 
and Gupta. 1 991 ) may result  in increased p late let sensit iv ity .  Such d isturbed 
state would ,  in turn , make it easier for p latelets to adhere and aggregate with 
the s l ightest stimulus. 
The suspected mechanism(s) of lead on vascu lar endothe l ium,  
p latelets and calcium levels and d istribut ion need to be studied further. 
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H owever, the s ignificant finding of th is work was that it evidenced enhanced 
p latelet aggregation as a resul t  of chron ic treatment with lead. As th is work 
was carried out in vivo, all poss ib le p latelet-endothe l ium interact ions were 
present. The reported increased susceptib i l ity to thrombosis in cerebral 
m icrovasculature is of s ignificance. Blood supply to the bra in  cou ld be 
severely d isrupted or completely blocked, thus producing hypoxic/ischemic 
condit ions,  with serious consequences. In  this context, the benefit of 
ant ithrombotic drugs to chronica l ly-exposed subjects needs to be explored. 
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CHAPTER VI 
CONCLUS ION 
The l i terature pertain ing to the adverse effects of exposure to lead i s  
very vast. Epidemiologica l  studies revea led a h igh  correlat ion between lead 
exposure and hypertension. Other stud ies have shown that other systems 
are also affected. Of more relevance to the present study are the effects of 
lead exposure on the central nervous, muscu lo-skeletal  and vascular 
systems. The muscle contract ion study pointed out that lead caused a 
decrease in  muscle tension and accelerated the muscle fat igue wh ich may 
impair  the muscular funct ion and cou ld  cause neuromuscu lar pathology when 
lead exposure is  in  excess.  Many in vitro experiments support our results .  
This  study showed that lead concentrat ion as low as 5 �m and 0. 1 
mg/kg produce neuromuscular impairment wh ich d isturbed the react ion t ime 
and strength of the flexor muscle of m ice. Such may lead to a complete stop 
of the react ion if there is a very high concentration for a longer t ime than 7 
days. More serious is the shorter t ime for the fi rst p late let aggregation in  
arterio les in  lead treated groups with the dose of  about 0. 1 mg/kg which wi l l  
stop the b lood supply to the bra in .  I f  the blood flow stops for more than 8 
min .  i t  wi l l  cause i rreversib le damage to bra in  t issues. 
Th is  work, as we l l  as previous studies ind icated different serious 
hea lth consequences of lead exposure to humans especia l ly  i n  developing 
countries. A major source of lead exposure is  leaded gaso l ine which i s  st i l l  i n  
use I n  spite of  i ts  adverse effects on health .  Thus. attempts to reduce the 
concentrat ion of lead in  the environment should be sought by: ( 1 )  contro l l ing 
the Industr ial  emiSSion of part icu late lead to the atmosphere, (2 )  monitor ing 
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i ndustria l  materia ls  which have a h igh content of lead and are very commonly 
used by trying to replace them with materia l s  of a lower lead content, (3) 
control of lead emissions from motor vehicles by reducing the level of lead 
content in gasol ine, by removing the particulate lead from vehicle exhaust 
gases, and by removing the lead from waste o i l  d i sposal ,  (4)  control of the 
ambient air qual ity standard of lead, (5) contro l  of the lead level with in the 
work p lace, (6) blood lead screen ing of people more exposed to lead, 
especia l ly chi ldren because they are more suscept ib le  to lead than adults. 
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GLO SSARY O F  TERM S AND DEFI NITIONS 
Aggregate growth 
AtaxIa 
Half  ( 1 /2 )  decay t Ime 
Mal leabi l ity 
Mean Ce l l  Hemoglobin 
(MCH)  
Mean cel l  hemog lobin 
concentrat ion (MCHC)  
The d ifference In  t ime between when blood flow 
stops and when fi rst p latelet aggregate appears . 
I rregulari ty in  muscular action through fai l ure of 
muscular coord inat ion. 
Half t ime needed for the muscle to reach the 
relaxation period start i ng from the h ighest 
response of the muscle to a st imulus.  
The abi l i ty of being hammered or ro l led out 
without breaking.  
The average amount of hemoglob in in  each red 
blood cel l ,  measured in p icogram (pg) .  Ca lculated 
by d iv id ing the total hemoglobin by the total 
number of red cel l s  and mu l t ip lying by 1 0. 
The average concentrat ion of hemog lobin in  each 
red cel l ,  measured i n  grams per deci l i ter (g/d l ) .  
Calcu lated by  d iv id ing the  total hemog lobin by  the 
hematocrit. 
Mean ce l l  
(MCV) 
volume The average volume of red blood ce l ls ,  measured 
in femtol i ters (fl ) ,  calculated by d iv id ing the packed 
ce l l  volume (hematocrit) by the red ce l l  count and 
mult ip ly ing by 1 0. 
Muscle fat igue 
Rise t ime 
The inabi l ity of the muscle to mainta in  its strength 
of contraction. 
Time required for the muscle to reach the h ighest 
response to a stimu lus start Ing from t ime of 
st imulus appl i cat ion.  
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Saturn ine 
Splayed galt  
Time to b lood flow 
stop 
Time to first p latelet 
aggregate 
Twitch tension 
Perta in ing to or produced by lead. 
A spread-out way of wa lk ing.  
The t ime ( in  seconds) elapsed from the beginn ing 
of the mercury l ight exposure on the crania l  
preparation unt i l  the platelet aggregates acclude 
the microvessels .  
The t ime in  seconds elapsed from the beginn ing of 
the mercury l ight exposure on the crania l  
preparation unti l the appearance of the first 
recognizable p late let aggregate. 
Rapid responses of a s ing le threshold or a greater 
stimu lus .  
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